Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Capital Reinvestment Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Capital Reinvestment Ratio of 0.92x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥126.49 Million) in capital expenditures (CN¥115.96 Million). See how much free cash does Jiangsu Canopus Wisdom Medical Technolog generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2024)
This chart tracks Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. For live market cap and broader valuation context, see 301290 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥126.49 Million | CN¥115.96 Million | ▲ +34.2% |
| 2023 | 0.68x | CN¥163.13 Million | CN¥111.46 Million | ▼ -13.0% |
| 2022 | 0.79x | CN¥94.63 Million | CN¥74.35 Million | ▲ +34.2% |
| 2021 | 0.59x | CN¥163.45 Million | CN¥95.67 Million | ▲ +162.6% |
| 2020 | 0.22x | CN¥114.07 Million | CN¥25.43 Million | — |